Dechra

Dechra, a UK-based Pharmaceutical Preparation Manufacturing company, reported total carbon emissions of approximately 146.3 million kg CO2e in 2022. This includes 7.6 million kg CO2e from Scope 1 emissions, 4.9 million kg CO2e from Scope 2 (location-based, or 6.2 million kg CO2e market-based), and about 132.5 million kg CO2e from Scope 3 emissions. Key contributors to Scope 3 emissions were purchased goods and services (approximately 54.5 million kg CO2e), capital goods (approximately 27.6 million kg CO2e), and upstream transportation and distribution (approximately 27.6 million kg CO2e).

In 2021, Dechra's total emissions were higher at approximately 168.4 million kg CO2e, with 10.2 million kg CO2e from Scope 1, 5.3 million kg CO2e from Scope 2 (market-based), and approximately 151.4 million kg CO2e from Scope 3.

Dechra has set ambitious climate commitments, validated by the Science Based Targets initiative (SBTi). The company is committed to achieving net-zero greenhouse gas emissions across its value chain by no later than 2050. Near-term targets include reducing absolute Scope 1 and 2 GHG emissions by 42% by 2030, from a 2021 base year. Additionally, Dechra aims to reduce Scope 3 GHG emissions by 51.6% per GBP value added within the same timeframe. For the long-term, Dechra commits to reducing absolute Scope 1 and 2 GHG emissions by 90% by 2050 from a 2021 base year, and Scope 3 GHG emissions by 97% per GBP value added within the same timeframe. These targets align with a 1.5°C global warming scenario.